• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高性能 P-手性膦配体的合成与应用。

Synthesis and applications of high-performance P-chiral phosphine ligands.

机构信息

Graduate School of Science, Chiba University.

出版信息

Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(9):520-542. doi: 10.2183/pjab.97.026.

DOI:10.2183/pjab.97.026
PMID:34759073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610783/
Abstract

Metal-catalyzed asymmetric synthesis is one of the most important methods for the economical and environmentally benign production of useful optically active compounds. The success of the asymmetric transformations is significantly dependent on the structure and electronic properties of the chiral ligands coordinating to the center metals, and hence the development of highly efficient ligands, especially chiral phosphine ligands, has long been an important research subject in this field. This review article describes the synthesis and applications of P-chiral phosphine ligands possessing chiral centers at the phosphorus atoms. Rationally designed P-chiral phosphine ligands are synthesized by the use of phosphine-boranes as the intermediates. Conformationally rigid and electron-rich P-chiral phosphine ligands exhibit excellent enantioselectivity and high catalytic activity in various transition-metal-catalyzed asymmetric reactions. Recent mechanistic studies of rhodium-catalyzed asymmetric hydrogenation are also described.

摘要

金属催化的不对称合成是经济且环境友好地生产有用的光学活性化合物的最重要方法之一。不对称转化的成功在很大程度上取决于与中心金属配位的手性配体的结构和电子性质,因此,高效配体的开发,特别是手性膦配体的开发,一直是该领域的重要研究课题。本文综述了具有磷原子手性中心的 P-手性膦配体的合成与应用。通过使用膦-硼烷作为中间体,合理设计了 P-手性膦配体。构象刚性和富电子的 P-手性膦配体在各种过渡金属催化的不对称反应中表现出优异的对映选择性和高催化活性。还描述了最近对铑催化不对称氢化反应的机理研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/6e283cce5dd6/pjab-97-520-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/cd8fd60158c6/pjab-97-520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/7ebf039a6207/pjab-97-520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/03da313c2807/pjab-97-520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/68ce9e5ef67e/pjab-97-520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/7af62a5f7e71/pjab-97-520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/f59f4002f0d1/pjab-97-520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d1b3ee52bb95/pjab-97-520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/74a802e4e9ee/pjab-97-520-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/ed1920908b29/pjab-97-520-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/88081c6a6f66/pjab-97-520-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/b8e8659d9512/pjab-97-520-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/de8b5b3063c2/pjab-97-520-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/4717163d21fc/pjab-97-520-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/8b028dad9459/pjab-97-520-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/2e52cf5e1903/pjab-97-520-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/67aa01f2204c/pjab-97-520-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/4f8ab280b43b/pjab-97-520-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/662444794f9c/pjab-97-520-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/5ee7a2e4bbf0/pjab-97-520-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/15be5811f4f6/pjab-97-520-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/b20c374da037/pjab-97-520-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/36169a3b114e/pjab-97-520-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/e781552d5169/pjab-97-520-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/9d912bdb27e7/pjab-97-520-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/a3eae630d5b9/pjab-97-520-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/3c918d595e29/pjab-97-520-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/38dd2047809e/pjab-97-520-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/09da6efd0ba0/pjab-97-520-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/7f7bc3a286a2/pjab-97-520-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d36baef50140/pjab-97-520-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/e6576c4faeab/pjab-97-520-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d999043dfa44/pjab-97-520-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/6b771c05ca0e/pjab-97-520-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/95905445fac3/pjab-97-520-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/058ebb9e8921/pjab-97-520-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/a2c46df7dab0/pjab-97-520-g036.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/9b3e9d59bea1/pjab-97-520-g037.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/436d63e1fb4d/pjab-97-520-g038.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d5f872ee72f0/pjab-97-520-g039.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/bd6df6ce2587/pjab-97-520-g040.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/88497ecc71d9/pjab-97-520-g041.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/b7e00329253d/pjab-97-520-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/6e283cce5dd6/pjab-97-520-g043.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/cd8fd60158c6/pjab-97-520-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/7ebf039a6207/pjab-97-520-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/03da313c2807/pjab-97-520-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/68ce9e5ef67e/pjab-97-520-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/7af62a5f7e71/pjab-97-520-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/f59f4002f0d1/pjab-97-520-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d1b3ee52bb95/pjab-97-520-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/74a802e4e9ee/pjab-97-520-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/ed1920908b29/pjab-97-520-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/88081c6a6f66/pjab-97-520-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/b8e8659d9512/pjab-97-520-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/de8b5b3063c2/pjab-97-520-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/4717163d21fc/pjab-97-520-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/8b028dad9459/pjab-97-520-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/2e52cf5e1903/pjab-97-520-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/67aa01f2204c/pjab-97-520-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/4f8ab280b43b/pjab-97-520-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/662444794f9c/pjab-97-520-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/5ee7a2e4bbf0/pjab-97-520-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/15be5811f4f6/pjab-97-520-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/b20c374da037/pjab-97-520-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/36169a3b114e/pjab-97-520-g022.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/e781552d5169/pjab-97-520-g023.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/9d912bdb27e7/pjab-97-520-g024.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/a3eae630d5b9/pjab-97-520-g025.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/3c918d595e29/pjab-97-520-g026.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/38dd2047809e/pjab-97-520-g027.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/09da6efd0ba0/pjab-97-520-g028.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/7f7bc3a286a2/pjab-97-520-g029.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d36baef50140/pjab-97-520-g030.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/e6576c4faeab/pjab-97-520-g031.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d999043dfa44/pjab-97-520-g032.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/6b771c05ca0e/pjab-97-520-g033.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/95905445fac3/pjab-97-520-g034.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/058ebb9e8921/pjab-97-520-g035.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/a2c46df7dab0/pjab-97-520-g036.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/9b3e9d59bea1/pjab-97-520-g037.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/436d63e1fb4d/pjab-97-520-g038.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/d5f872ee72f0/pjab-97-520-g039.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/bd6df6ce2587/pjab-97-520-g040.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/88497ecc71d9/pjab-97-520-g041.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/b7e00329253d/pjab-97-520-g042.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2162/8610783/6e283cce5dd6/pjab-97-520-g043.jpg

相似文献

1
Synthesis and applications of high-performance P-chiral phosphine ligands.高性能 P-手性膦配体的合成与应用。
Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(9):520-542. doi: 10.2183/pjab.97.026.
2
Chiral diphosphine and monodentate phosphorus ligands on a spiro scaffold for transition-metal-catalyzed asymmetric reactions.用于过渡金属催化不对称反应的螺环骨架上的手性双膦和单齿磷配体
Acc Chem Res. 2008 May;41(5):581-93. doi: 10.1021/ar700137z. Epub 2008 Mar 1.
3
Searching for Practically Useful P-Chirogenic Phosphine Ligands.寻找具有实际用途的P-手性膦配体。
Chem Rec. 2016 Dec;16(6):2655-2669. doi: 10.1002/tcr.201600098. Epub 2016 Aug 15.
4
Iridium-Catalyzed Asymmetric Hydrogenation of Unsaturated Carboxylic Acids.铱催化的不饱和羧酸的不对称氢化反应。
Acc Chem Res. 2017 Apr 18;50(4):988-1001. doi: 10.1021/acs.accounts.7b00007. Epub 2017 Apr 4.
5
A novel chiral ferrocenyl phosphine ligand from sugar: applications in Rh-catalyzed asymmetric hydrogenation reactions.一种源自糖类的新型手性二茂铁基膦配体:在铑催化的不对称氢化反应中的应用。
Org Lett. 2002 Dec 12;4(25):4471-4. doi: 10.1021/ol0269998.
6
Highly Efficient Asymmetric Hydrogenation Catalyzed by Iridium Complexes with Tridentate Chiral Spiro Aminophosphine Ligands.由具有三齿手性螺环氨基膦配体的铱配合物催化的高效不对称氢化反应
Acc Chem Res. 2023 Feb 7;56(3):332-349. doi: 10.1021/acs.accounts.2c00764. Epub 2023 Jan 23.
7
Asymmetric hydrogenation of unsaturated ureas with the BIPI ligands.使用BIPI配体对不饱和脲进行不对称氢化。
Org Lett. 2008 Jan 17;10(2):341-4. doi: 10.1021/ol7028542. Epub 2007 Dec 21.
8
Synthesis of iridium and rhodium complexes with new chiral phosphine-NHC ligands based on 1,1'-binaphthyl framework and their application in asymmetric hydrogenation.基于 1,1'-联萘骨架的新型手性膦-NHC 配体的铱和铑配合物的合成及其在不对称氢化中的应用。
Dalton Trans. 2013 Oct 7;42(37):13599-606. doi: 10.1039/c3dt51141c. Epub 2013 Jul 30.
9
Tunable asymmetric catalysis through ligand stacking in chiral rigid rods.通过手性刚性棒中的配体堆积实现可调非对映选择性催化。
J Am Chem Soc. 2013 Nov 27;135(47):17687-90. doi: 10.1021/ja408860s. Epub 2013 Nov 15.
10
Chiral 1-phenylethylamine-derived phosphine-phosphoramidite ligands for highly enantioselective Rh-catalyzed hydrogenation of beta-(acylamino)acrylates: significant effect of substituents on 3,3'-positions of binaphthyl moiety.手性 1-苯乙胺衍生的膦-磷酰胺配体在 Rh 催化的 β-(酰氨基)丙烯酸盐高对映选择性氢化中的应用:双萘基部分 3,3'-位取代基的显著影响。
Org Biomol Chem. 2010 May 21;8(10):2320-2. doi: 10.1039/c000268b.

引用本文的文献

1
Insights into the synthesis and structural properties of pro-chiral 2-acetyl--aryl-2-(prop-2-yn-1-yl)pent-4-ynamides/-2-allyl-4-enamide derivatives through kinetics and energy frameworks.通过动力学和能量框架深入了解前手性2-乙酰基-芳基-2-(丙-2-炔-1-基)戊-4-炔酰胺/-2-烯丙基-4-烯酰胺衍生物的合成及结构性质
RSC Adv. 2025 May 12;15(20):15712-15723. doi: 10.1039/d5ra02166a.
2
Rhodium(I) Complexes with a η-Fluorenyl--phosphanylphosphorane Ligand.具有η-芴基-膦基膦烷配体的铑(I)配合物
Inorg Chem. 2024 Jul 29;63(30):13820-13824. doi: 10.1021/acs.inorgchem.4c01934. Epub 2024 Jul 18.
3
Palladium-catalyzed regio- and stereo-selective phosphination of cyclic biarylsulfonium salts to access atropoisomeric phosphines.

本文引用的文献

1
Cobalt-Catalyzed Chemo- and Enantioselective Hydrogenation of Conjugated Enynes.钴催化的共轭烯炔的化学选择性和对映选择性氢化反应。
Angew Chem Int Ed Engl. 2021 Jul 26;60(31):16989-16993. doi: 10.1002/anie.202106566. Epub 2021 Jun 24.
2
Backbone-Modified -Symmetrical Chiral Bisphosphine TMS-QuinoxP*: Asymmetric Borylation of Racemic Allyl Electrophiles.骨架修饰的对称手性双膦配体 TMS-QuinoxP*:外消旋烯丙基亲电试剂的不对称硼化反应。
J Am Chem Soc. 2021 May 5;143(17):6413-6422. doi: 10.1021/jacs.0c08899. Epub 2021 Apr 23.
3
The Discovery of Multifunctional Chiral P Ligands for the Catalytic Construction of Quaternary Carbon/Silicon and Multiple Stereogenic Centers.
钯催化环状联芳基锍盐的区域和立体选择性膦化反应以制备阻转异构膦。
Chem Sci. 2024 Apr 9;15(18):6943-6948. doi: 10.1039/d4sc00446a. eCollection 2024 May 8.
4
Synthesis of -stereogenic 1-phosphanorbornane-derived phosphine-phosphite ligands and application in asymmetric catalysis.- 手性1-磷杂降冰片烷衍生的膦-亚磷酸酯配体的合成及其在不对称催化中的应用。
RSC Adv. 2023 Nov 24;13(49):34439-34444. doi: 10.1039/d3ra07630j. eCollection 2023 Nov 22.
5
Access to Enantiomerically Pure -Chiral 1-Phosphanorbornane Silyl Ethers.获得对映体纯的 - 手性1-磷杂降冰片烷硅醚。
Molecules. 2023 Aug 23;28(17):6210. doi: 10.3390/molecules28176210.
6
Universal and divergent P-stereogenic building with camphor-derived 2,3-diols.具有樟脑衍生的2,3-二醇的通用且多样的P-手性结构单元。
Commun Chem. 2023 Jun 27;6(1):133. doi: 10.1038/s42004-023-00935-0.
7
New Optically Active -Butylarylthiophosphinic Acids and Their Selenium Analogues as the Potential Synthons of Supramolecular Organometallic Complexes: Syntheses and Crystallographic Structure Determination.新型光学活性 -丁基芳基硫代膦酸及其硒类似物作为超分子有机金属配合物的潜在前体:合成与晶体结构测定。
Molecules. 2023 May 24;28(11):4298. doi: 10.3390/molecules28114298.
8
Organocatalytic asymmetric synthesis of P-stereogenic molecules.P-手性分子的有机催化不对称合成。
Front Chem. 2023 Feb 16;11:1132025. doi: 10.3389/fchem.2023.1132025. eCollection 2023.
9
Enantioselective hydrogen-bond-donor catalysis to access diverse stereogenic-at-P(V) compounds.对映选择性氢键供体催化构建多样的手性膦(V)化合物。
Science. 2022 Jun 10;376(6598):1230-1236. doi: 10.1126/science.abp8488. Epub 2022 Jun 9.
多功能手性 P 配体的发现及其在手性季碳/硅和多立体中心构建中的催化作用。
Acc Chem Res. 2021 Jan 19;54(2):452-470. doi: 10.1021/acs.accounts.0c00740. Epub 2020 Dec 30.
4
Noncovalent Interaction-Assisted Ferrocenyl Phosphine Ligands in Asymmetric Catalysis.非共价相互作用辅助的二茂铁基膦配体在不对称催化中的应用
Acc Chem Res. 2020 Sep 15;53(9):1905-1921. doi: 10.1021/acs.accounts.0c00347. Epub 2020 Aug 27.
5
P-Stereogenic Amino-Phosphines as Chiral Ligands: From Privileged Intermediates to Asymmetric Catalysis.手性膦-氨基酸配体作为手性配体:从优势中间体到不对称催化。
Acc Chem Res. 2020 Mar 17;53(3):676-689. doi: 10.1021/acs.accounts.9b00633. Epub 2020 Feb 27.
6
A Bulky Three-Hindered Quadrant Bisphosphine Ligand: Synthesis and Application in Rhodium-Catalyzed Asymmetric Hydrogenation of Functionalized Alkenes.一种庞大的三环双膦配体:在铑催化的官能化烯烃不对称氢化反应中的合成与应用。
Org Lett. 2019 Nov 15;21(22):8874-8878. doi: 10.1021/acs.orglett.9b02702. Epub 2019 Oct 17.
7
Copper(I)-Catalyzed Enantioconvergent Borylation of Racemic Benzyl Chlorides Enabled by Quadrant-by-Quadrant Structure Modification of Chiral Bisphosphine Ligands.铜(I)催化的外消旋苄基氯化物的对映转化硼化反应,通过手性双膦配体的象限-象限结构修饰来实现。
Angew Chem Int Ed Engl. 2019 Aug 5;58(32):11112-11117. doi: 10.1002/anie.201906011. Epub 2019 Jul 3.
8
Nickel-Catalyzed Asymmetric Hydrogenation of N-Sulfonyl Imines.镍催化的N-磺酰基亚胺的不对称氢化反应。
Angew Chem Int Ed Engl. 2019 May 27;58(22):7329-7334. doi: 10.1002/anie.201902576. Epub 2019 Apr 23.
9
P-Chiral Phosphorus Ligands Based on a 2,3-Dihydrobenzo[ d][1,3]oxaphosphole Motif for Asymmetric Catalysis.基于 2,3-二氢苯并[ d][1,3]氧杂磷杂环戊烯骨架的手性磷配体在不对称催化中的应用。
Acc Chem Res. 2019 Apr 16;52(4):1101-1112. doi: 10.1021/acs.accounts.9b00029. Epub 2019 Mar 8.
10
Enantioselective Allylation Using Allene, a Petroleum Cracking Byproduct.使用石油裂化副产物丙二烯进行对映选择性烯丙基化反应。
J Am Chem Soc. 2019 Feb 13;141(6):2251-2256. doi: 10.1021/jacs.8b13907. Epub 2019 Feb 1.